Mary Lynne Hedley Eli Lilly & CO (LLY) insider trading activity

Mary Lynne Hedley is Director of ELI LILLY & Co. Currently has a direct ownership of 1,959 shares of LLY, which is worth approximately $1.54 Million. The most recent transaction as insider was on May 15, 2023, when has been sold 23 shares (Common Stock) at a price of $434.51 per share, resulting in proceeds of $9,993. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.96K

2.14% 3M change

30.34% 12M change

Total Value Held $1.54 Million

Mary Lynne Hedley Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 15 2023	BUY Grant, award, or other acquisition	$9,993 $434.51 p/Share	23 Added 2.36%	953 Common Stock
Apr 17 2023	BUY Grant, award, or other acquisition	$10,053 $372.35 p/Share	27 Added 2.82%	930 Common Stock
Mar 20 2023	BUY Grant, award, or other acquisition	$10,008 $333.6 p/Share	30 Added 4.38%	655 Common Stock
Feb 21 2023	BUY Grant, award, or other acquisition	$9,825 $327.51 p/Share	30 Added 4.59%	623 Common Stock
Jan 17 2023	BUY Grant, award, or other acquisition	$10,016 $357.74 p/Share	28 Added 4.51%	593 Common Stock
Dec 19 2022	BUY Grant, award, or other acquisition	$10,017 $357.78 p/Share	28 Added 4.72%	565 Common Stock
Nov 21 2022	BUY Grant, award, or other acquisition	$129,660 $361.17 p/Share	359 Added 40.11%	536 Common Stock
Oct 17 2022	BUY Grant, award, or other acquisition	$9,983 $332.76 p/Share	30 Added 14.49%	177 Common Stock
Sep 19 2022	BUY Grant, award, or other acquisition	$10,068 $305.09 p/Share	33 Added 18.33%	147 Common Stock
Aug 15 2022	BUY Grant, award, or other acquisition	$10,046 $313.94 p/Share	32 Added 21.92%	114 Common Stock
Jul 18 2022	BUY Grant, award, or other acquisition	$9,975 $321.77 p/Share	31 Added 27.43%	82 Common Stock
Jun 21 2022	BUY Grant, award, or other acquisition	$9,812 $297.34 p/Share	33 Added 39.29%	51 Common Stock
May 16 2022	BUY Grant, award, or other acquisition	$5,389 $299.38 p/Share	18 Added 50.0%	18 Common Stock

Also insider at

VEEV

VEEVA SYSTEMS INC Healthcare

Director

CNTA

Centessa Pharmaceuticals plc Healthcare

Director

MLH